CHENGDU, China, Sept. 22, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new drug application (NDA) for the Company's small molecule rearranged ...
The National Institute for Health and Care Excellence (NICE) has issued final guidance approving selpercatinib (Retsevmo, Eli Lilly) for treating advanced thyroid cancer with RET alterations both in ...
A total of 291 patients with progressive RET-mutant MTC and no prior history of MKI therapy for advanced or metastatic disease were randomized in the study. One hundred and ninety-three patients were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback